Dr. Miri Halperin Wernli

President; Board Director; Chair of Technology Evaluation, Acquisition and Scientific Integrity Board Committee

Dr. Halperin Wernli is a senior pharmaceutical and biomedical executive with over 30 years of strategic and operational leadership in the biopharmaceutical industry and a deep understanding of clinical psychiatry and of drug and product development in heavy regulated environments.

Dr. Halperin Wernli co-founded Creso Pharma, a cannabis company, and listed the company on the Australian Stock exchange (ASX) in October 2016. She is the Group CEO as well as an Executive Director on the Board. Creso develops cannabis and hemp-derived therapeutic, nutraceutical, and lifestyle products with wide patient and consumer reach for human and animal health. Creso uses GMP development and manufacturing standards for its products as a reference of quality excellence with initial product registrations in Switzerland and has worldwide rights for a number of unique and proprietary innovative delivery technologies which enhance the bioavailability and absorption of cannabinoids. Creso’s products are currently commercialized in Switzerland, Europe, Oceania, South Africa and soon in Latin America.

Prior to founding Creso Pharma Dr. Halperin Wernli worked in clinical psychiatry in Swiss academic hospital settings and then held various global senior leadership positions in the pharma and biotech industries in Switzerland and in the US (Merck, Sharp and Dohme, Roche and Actelion pharmaceuticals) covering Product Development, R&D, and Strategic Marketing. Her extensive pharmaceutical industry and biomed research and development experience covers the full spectrum of areas and activities from Preclinical to Clinical Development and Strategy, to Drug Registration and Launch, across several Therapeutic Areas.

Dr. Halperin Wernli is a skilled clinician in child and adult psychiatry and an experienced Pharmaceutical leader with skills and broad expertise in Drug Development, Regulatory Affairs, Project & Portfolio Management, Development Finance & Controlling, and Corporate Strategy and Governance.

JR Rahn Portrait

JR Rahn

Co-Founder, Board Director & Co-CEO

Stephen L. Hurst, JD Portrait

Stephen L. Hurst, JD

Co-Founder, Executive Chair of the Board & Co-CEO

Leonard Latchman Portrait

Leonard Latchman

Co-founder

Dr. Miri Halperin Wernli Portrait

Dr. Miri Halperin Wernli

President; Board Director; Chair of Technology Evaluation, Acquisition and Scientific Integrity Board Committee

Carol Nast Portrait

Carol Nast

Chief Operating Officer

Donald Gehlert, PhD Portrait

Donald Gehlert, PhD

Chief Scientific Officer

Dave Guebert Portrait

Dave Guebert

Chief Financial Officer

Jeanne Bonelle Portrait

Jeanne Bonelle

EVP, Technical Operations

Shahera St. John Portrait

Shahera St. John

VP, Programs

Nico Forte Portrait

Nico Forte

Senior Director, Business Operations and Development

Carole Abel Portrait

Carole Abel

Senior Director Clinical Operations & Program Leader LSD

Madeline Feldman Portrait

Madeline Feldman

Director of Operations & Administration

Collin Gage Portrait

Collin Gage

Head of Corporate Development

Rachann McKnight Portrait

Rachann McKnight

Director, Business Process

Jon Polaha Portrait

Jon Polaha

Financial Analyst

Stanley D. Glick, PhD, MD Portrait

Stanley D. Glick, PhD, MD

Board Director and Chair Scientific Advisory Board

Natalie Wheeler, PhD Portrait

Natalie Wheeler, PhD

Medical Science Liaison with Dova Pharmaceuticals

Matthew W. Johnson, Ph.D Portrait

Matthew W. Johnson, Ph.D

Clinical Advisor

Kenneth Alper, MD Portrait

Kenneth Alper, MD

Clinical Associate Professor of Psychiatry and Neurology at the New York University School of Medicine

Dr. Peter Gasser Portrait

Dr. Peter Gasser

Clinical Advisor

Professor Dr. Matthias Liechti, PhD & M.D. Portrait

Professor Dr. Matthias Liechti, PhD & M.D.

Scientific Collaborator & Advisor

Dr. Kim Kuypers Portrait

Dr. Kim Kuypers

Scientific Collaborator & Advisor

Sarah McCallum, PhD Portrait

Sarah McCallum, PhD

Associate Professor of Neuroscience and Experimental Therapeutics (DNET) at Albany Medical College

John Rotrosen, MD Portrait

John Rotrosen, MD

Professor of Psychiatry with New York University’s Langone’s Department of Psychiatry

Brigid Makes Portrait

Brigid Makes

Board Director, Chair of Audit Commitee, Member of Compensation, Nomination and Governance Committee

Perry Dellelce Portrait

Perry Dellelce

Board Director, Member of Audit and Compensation, Nomination and Governance Committees

Bruce Linton Portrait

Bruce Linton

Board Director, Chair of Compensation, Nomination and Governance Committee, Member of Audit Committee

Scott Freeman, MD Portrait

Scott Freeman, MD

Co-Founder & Clinical Advisor